Carson Chrenek
Overview
Explore the profile of Carson Chrenek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chrenek C, Duong B, Khullar A, McRee C, Thomas R, Swainson J
Front Psychiatry
. 2024 Jan;
14:1283733.
PMID: 38260793
Background: Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to be efficacious for treatment-resistant depression (TRD), access to each of these treatments within healthcare systems is limited due...
2.
Chubbs B, Wang J, Archer S, Chrenek C, Khullar A, Wolowyk M, et al.
Front Psychiatry
. 2022 Dec;
13:1016439.
PMID: 36465297
Ketamine has gained rapid popularity as a treatment option for treatment resistant depression (TRD). Though seen only in limited contexts, ketamine is a potential drug of abuse, addiction and diversion....
3.
Swainson J, Thomas R, Archer S, Chrenek C, MacKay M, Baker G, et al.
Expert Rev Neurother
. 2019 Jul;
19(10):899-911.
PMID: 31282772
: Treatment Resistant Depression (TRD) is a common and burdensome condition with poor outcomes and few treatment options. Esketamine is the S-enantiomer of ketamine and has recently been FDA approved...
4.
Lee V, Archer S, Chrenek C, Swainson J
J Psychopharmacol
. 2019 Feb;
33(2):258-259.
PMID: 30773111
No abstract available.
5.
Archer S, Chrenek C, Swainson J
J Clin Psychopharmacol
. 2018 Jun;
38(4):380-384.
PMID: 29912788
Background: Previous studies have demonstrated ketamine to have a rapid antidepressant effect in some patients with treatment-resistant depression (TRD), but the effect is unfortunately not sustained in the long term....